Pancreatic cancer survival has finally doubled in a decade to 13 percent, a fragile but real sign that years of slow, ...

The trial at UT Southwestern Medical Center involves an innovative chemotherapy treatment for patients with locally advanced ...

Pancreatic cancer, also known as pancreatic ductal adenocarcinoma, is one of the most aggressive types of cancer. Despite ...

KRAS inhibitors, cancer vaccines, and cell therapies are promising advancements in pancreatic cancer treatment, potentially improving patient outcomes. Innovative drug delivery techniques aim to ...

A new study has found for the first time that magnetoelectric nanoparticles—tiny, wirelessly controlled particles activated ...

Baseline quality of life scores predicted survival in patients with non-metastatic advanced pancreatic cancer, with ...

Last year, researchers at the University of California, Riverside, developed a novel “molecular crowbar” strategy to degrade ...

BOSTON, SAN DIEGO, and CALGARY, AB, Sept. 26, 2023 /PRNewswire/ -- In an effort to continue accelerating new treatment options for people with pancreatic cancer, the Pancreatic Cancer Action Network ...

While some risk factors for cancer can be mitigated through lifestyle choices such as diet or exercise, aging is not one of ...

We urge policymakers and the public to stand together to protect and expand funding for cancer research. Progress is not ...

Treating pancreatic cancer remains one of oncology’s greatest challenges. The disease is often diagnosed at an advanced stage, progresses rapidly, and responds poorly to existing treatments.